6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10705 | CCG 203769 | 4-butyl-2-ethyl-1,2,4-thiadiazolidine-3,5-dione,RGS4 inhibitor 11b,Thiadiazolidinone (TDZD) deriv. 6 | GSK-3 , GTPase , Dopamine Receptor |
CCG 203769 (Thiadiazolidinone (TDZD) deriv. 6) is a selective inhibitor of RGS4 with an IC50 of 17 nM for the RGS4-Gαo protein-protein interaction. | |||
T3217 | PF-CBP1 hydrochloride | PF-CBP1 HCl | Epigenetic Reader Domain , Histone Acetyltransferase |
PF-CBP1 hydrochloride (PF-CBP1 HCl) is a highly selective inhibitor of the bromodomain of CREB-binding protein(CREBBP).It inhibits CREBBP and p300 bromodomains with IC50 of 125 and 363 nM respectively. | |||
T14897 | CCG-63802 | GTPase | |
CCG-63802 is a reversible inhibitor of the regulator of G-protein signaling (RGS) protein and has the greatest potency at RGS4. | |||
T6434 | CCG-50014 | CCG 50014 | GTPase |
CCG-50014 is a potent and selective inhibitor of RGS4 with IC50 of 30 nM. | |||
T14898 | CCG-63808 | GTPase | |
CCG-63808 is a reversible inhibitor of regulator of G-protein signaling (RGS) proteins. CCG-63808 dose-dependently inhibits the TR-FRET signal between RGS4-AF488 and Tb-Gαo with IC50 values of 1.9 μM. | |||
T73348 | CCG-2046 | ||
CCG-2046 is a chemical inhibitor targeting RGS4, demonstrating an inhibition concentration (IC50) of 4.3 μM for the interaction between RGS4 and Gαo signal. |